(ORDO NEWS) — Documents released by the FDA under the Freedom of Information Act (FOIA) show that Pfizer has reported 1,223 vaccine-related deaths since December 1. 2020 to 28 February 2021.
Tens of thousands of other serious adverse reactions were noted, but the emergency authorization for these products was still in effect.
The FDA is trying to ban the publication of other related documents until 2076.
A Freedom of Information Act (FOIA) request made by the Public Health and Medical Professionals for Transparency group showed that Pfizer was aware of 1,223 potential vaccine-related deaths within the first 90 days of COVID vaccine initiation.
The Public Health and Healthcare Workers for Transparency group consists of about 30 professors and scientists who demand transparency in medicine – something that society should not fight for.
Table 1. Pfizer records 42,086 reactions to their COVID-19 vaccine in the 90-day period from December 1st. 2020 – 28 February 2021. 25,379 reactions were “medically confirmed” and 16,707 were “medically unconfirmed”. Pfizer has also revised the total number of vaccine doses administered up to this point.
According to Pfizer, a medically unconfirmed event occurs as a result of reports that come in without medical records or other necessary documents to confirm.
Pfizer also notes that,
“In some reports, clinical information (such as medical history, confirmation of diagnosis, time from drug intake to onset of illness, dose and use of concomitant drugs) is missing or incomplete, and follow-up information may not be available.”
“Accumulation of reported adverse events (ADs) does not necessarily indicate that a particular AD was caused by a drug; rather, the event could be caused by an underlying medical condition or some other factor (s), such as past medical history or concomitant medications.”
Pfizer document.
The documents also showed that Pfizer was well aware of tens of thousands of other adverse and serious adverse reactions in the months following drug distribution. These include 1,403 cases of cardiovascular problems and many cases of cardiac complications caused by the vaccine.
The FOIA’s request for these documents was forwarded to the Food and Drug Administration (FDA), which initially did not provide them. The court order forced them to comply and start issuing documents. The joint court ruling explains that the FDA has proposed 500 pages per month. Based on the calculated number of pages, this would mean that the FDA will complete the filing in almost 55 years, in 2076. This is how long it will take for the public to gain clarity on why the FDA approved these vaccines.
“Until the full volume of documents provided by Pfizer to the FDA has been made available, proper review by independent scientists who are members of the Claimant is not possible.” Would the FDA agree to review and license this product without all the paperwork? Of course not. These independent, internationally renowned scientists must be provided immediately. ”
Court statement
This is not surprising: A systematic review of the journal PLOS analyzed 28 studies and found that adverse events were less likely to appear in published journal articles than in unpublished studies (such as industry-held data).
Other details regarding Pfizer’s trials came from whistleblower Brooke Jackson’s testimony . An article in the British Medical Journal shed light on her claims that some of the test data for the Pfizer COVID vaccine was falsified. The company she worked for, Ventavia, one of the companies contracted to conduct vaccine trials for Pfizer, even tried to discredit her claims as false by claiming that she did not work on the Pfizer trials. But later published documents showed that Ventavia was lying .
New Pfizer data documents will be released in the coming weeks. Public Health and Medical Professionals for Transparency has filed another motion that will force the FDA to expedite the release of the requested documents.
Despite the findings in this first batch of documents, the FDA has nevertheless considered it necessary and appropriate to authorize emergency use of these products. However, those affected by COVID vaccines are not eligible for compensation under the Vaccine Injury Compensation Program .
Today, this program protects pharmaceutical companies from liability, and payments to victims are carried out at the expense of taxpayers. To date, the program has disbursed over US $ 4 billion to people and families of vaccine victims in the United States. Vaccines are not liability products.
Since the introduction of COVID vaccines, vaccine-related adverse event reporting systems around the world have recorded a record number of injuries. By October 15, 2021, in the World Health Organization (WHO) VigiAccess reporting system, the number of adverse events reported worldwide exceeded 2,344,240 for COVID vaccines alone.
Many researchers also point to the possibility of underreporting the number of reports. According to numerous studies, it is known that very few serious adverse reactions to prescription drugs, for example, are reported, possibly up to 95%.
But what about serious adverse reactions to vaccines? A study published October 7, 2021 in the journal Toxicology Reports suggests that underreporting deaths from COVID vaccines could have resulted in a number 1,000 times fewer than the actual number.
They also cite the widespread Harvard Pilgrim study published in 2010, which suggests that less than 1 percent of vaccine injuries are reported. This includes serious adverse reactions.
Approximately 50 percent of COVID vaccine injuries reported to the Vaccine Adverse Events Reporting System in the past 30 years are all COVID shot injuries. As of 15 October 2021, the Vaccine Adverse Event Reporting System (VAERS) had reported 122,833 serious adverse events, of which 17,128 were fatal, following the administration of COVID vaccines. This includes cases from all over the world, not just the United States. The latest data can be viewed here .
—
Online:
Contact us: [email protected]
Our Standards, Terms of Use: Standard Terms And Conditions.